1-74041727-G-A
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_001105659.2(LRRIQ3):c.1204C>T(p.Arg402Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000793 in 1,613,300 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001105659.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000527 AC: 8AN: 151876Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000844 AC: 21AN: 248900Hom.: 0 AF XY: 0.0000889 AC XY: 12AN XY: 135038
GnomAD4 exome AF: 0.0000821 AC: 120AN: 1461424Hom.: 0 Cov.: 32 AF XY: 0.0000825 AC XY: 60AN XY: 727004
GnomAD4 genome AF: 0.0000527 AC: 8AN: 151876Hom.: 0 Cov.: 32 AF XY: 0.0000540 AC XY: 4AN XY: 74140
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 20, 2024 | The c.1204C>T (p.R402W) alteration is located in exon 7 (coding exon 6) of the LRRIQ3 gene. This alteration results from a C to T substitution at nucleotide position 1204, causing the arginine (R) at amino acid position 402 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2024 | LRRIQ3: BP4 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at